Richard Ransohoff is the founder of Abata Therapeutics. Abata Therapeutics has raised $95M in total funding. Latest round: Seed.
Richard Ransohoff, a former Biogen executive, co-founded Abata Therapeutics. The company, seeded by Third Rock, focuses on developing cell therapies to treat autoimmune diseases, particularly multiple sclerosis. Abata Therapeutics secured $95 million in funding in 2021.
Full founder directory · Investor directory · Company funding database · Fundraising library